Dr. Rhoda M. Alani, MD

Dr. Alani practices at Boston Medical Center in Boston, Massachusetts, part of Boston Medical Center Health System.

Dr. Alani's NPI, 1154385268, was assigned on April 14, 2006. Dr. Alani graduated from University Of Michigan Medical School in 1991. Dr. Alani holds Massachusetts license 81195.

Dr. Alani's primary practice is Boston Medical Center, at 1 Boston Medical Center Place, Boston, MA 02118 in Suffolk County. The practice phone is (617) 638-8000.

Dr. Alani's primary practice is Boston Medical Center in Boston, Massachusetts, part of Boston Medical Center Health System. The medical group on file is DotHouse Health. Dmand AI also links Dr. Alani to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Alani practices, 3 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Alani's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Alani is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Alani's licenses on file in 2 states: Massachusetts and Maryland.

Dmand AI lists acne, benign or precancerous skin growths, contact dermatitis, itchy rashes, scalp rash, shingles and skin cyst among the conditions Dr. Alani treats.

CMS data shows 17 Medicare services from Dr. Alani across 1 procedure code in 2024, all of them office visits, for 33 Medicare patients. Medicare paid $790 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 33 Medicare patients who saw Dr. Alani in 2024. The largest group is 65 to 74, with 16 patients. 75% of them have high blood pressure, and 58% have high cholesterol. Their average risk score is 1.09, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Alani's median patient age at 64, with 61% women.

In 2022, Dr. Alani wrote 11 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $238 in total drug cost. In 2021, CMS named 18 claims across 1 drug.

Dr. Alani accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 39 procedures of removal of skin lesions by Dr. Alani, more than 70% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 80 papers to Dr. Alani, published from 2001 to 2025. 2024 was the busiest year, with 5. The most frequent topics are Melanoma, Skin Neoplasms and Cell Line, Tumor. Dr. Alani has published most often in J Invest Dermatol. Dr. Alani's most frequent co-authors are Philip A. Cole, MD, Frederick Thomas Gibson and Michael Timothy Smith, MD.

Dmand AI links Dr. Alani to 1 clinical trial. Conditions studied include Melanoma and Nevi and Melanomas.

CMS Open Payments shows 1 general payment to Dr. Alani from 1 drug or device company in 2016. Food and beverage make up the largest share, 100% of the total. Genentech, Inc. paid the most, $20.

Dmand AI lists 2 awards for Dr. Alani.

Dr. Alani graduated from University Of Michigan Medical School in 1991.

Dr. Alani is in network with 11 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.